About

Founded

2016

Headquarters

Montbonnot-Saint-Martin, France

Industry

Hardware, Healthcare

Company Description

Remedee Labs aims to change people’s lives thanks to a patient-centric digital service platform using the first endorphin stimulator. 1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life.

Quick Links

Website Jobs

Funding

Total Raised

$24.8 million

Valuation

Undisclosed

Significant Investors

Generali France, Hardware Club, Habert Dassault Finance

Company Traction

As of December 2022, Remedee Labs’ reported 8/10 patients using its chronic pain solution, Remedee Well, said there was a significant improvement in their quality of life.

Leadership Team

David Crouzier: Co-Founder & CEO of Remedee Labs. Former Head of Risk Emerging Technologies Laboratory at Service de Santé des Armées (SSA).

Jacques Husser: Co-Founder & Executive Chairman of Remedee Labs. Former COO at SIGFOX.

Michael Foerster: Co-Founder & CTO of Remedee Labs. Former Co-Founder & CTO of Nivolog.

Jérémy Sarmeo: CFO at Remedee Labs. Former Senior Manager Audit at EY.

Jerome Chaudeurge: Head of Product and Services at Remedee Labs. Former Director, Global Digital Marketing Head, Sanofi Diabetes Cardiovascular GBU at Sanofi.

Press

Bioworld (December 28, 2022): Remedee cures funding pains with $13.35M in funding round

Fierce Biotech (May 19, 2021): Sanofi digital health VP jumps ship for pain management developer Remedee Labs

Remedee Labs